Skip to main content

Table 2 Three pathways basically implicated and associated with SARS-CoV-2 [188]

From: Aggravating mechanisms from COVID-19

Classification

Mechanism

Signaling pathways

Viral Pathogenesis

1. ACE2 and TLR pathway

1S-protein has been proposed to have the most substantial protein‒protein interaction with TLR4 [55,56,57,58,59,60]

2TLR2 and TLR4 are expressed intracellularly in dendritic, epithelial, and endothelial cells. TLRs in modulation of COVID-19 cytokine storm signaling in SARS-CoV-2 [50, 60,61,62,63]

Neurological symptoms induced by TLRs or S-protein [50, 59,60,61, 63]. Clinically evident or exacerbated with viral diseases or aging [64, 65]

2. Neuropilin‑1 pathway

3NRP1 acts as a host cell mediator that can increase SARS-CoV-2 infectivity and contribute to its tissue/organ tropism [66,67,68]

NRPs are associated with numerous signaling pathways: 4VEGF [68], 5EGF [69], 6FGF [70], 7HGF [71, 72], 8IGF [73], 9PDGF [74, 75], 10TGFβ [76], and 11DPP-4 [77]

NRP-1 functions as a coreceptor for VEGF, HGF, PDGF, EGF, FGF, IGF, TGFβ, and DPP4, functionally involved in the migration and invasion of various cells, membrane disorders, angiogenesis as a hub receptor in the vascular system [78]

3. Spike protein pathway

The interaction of 12ACE2–TLRs with SARS-CoV-2 S-protein in human 13VSELs and 14HSCs activates the NLRP3 inflammasome [57, 62, 79,80,81]

S-protein activates the NLRP3 Inflammasome and ACE2 is expressed on very small CD45 − precursors of hematopoietic and endothelial Cells and in Response to NLRP3 inflammasome with distinct epigenetic and gene expression signatures [82]

15PF4 dependent syndrome

16AESI [81, 83,84,85]

  1. 1S-protein (SARS-CoV-2 Spike protein), 2TLR4 (Toll-Like Receptor 4), 3NRP1 (Neuropilin 1), 4VEGF (Vascular Endothelial Growth Factor), 5EGF (Epidermal Growth Factor), 6FGF (Fibroblast Growth Factor), 7HGF (Hepatocyte Growth Factor), 8IGF (Insulin-Like Growth Factor), 9PGGF (Platelet-Derived Growth Factor), 10TGFβ (Transforming growth factor-β), 11DPP-4 (Dipeptidyl peptidase 4), 12ACE2 (Angiotensin Converting Enzyme 2), 13VSEL (Very small numbers of embryonic-like stem cells), 14HSC (hematopoietic stem cell), 15PF4 (pathogenic platelet factor 4), 16AESI (Adverse Event of Special Interest)